Dr Marina Pajic receives her award from Professor David Currow (CEO, Cancer Institute NSW)
22 November 2017
Dr Pajic’s award was announced at the NSW Premier’s Awards for Outstanding Cancer Research 2017, held at the Four Seasons Sydney on Friday, November 3.
Dr Pajic has been supported by CINSW for the past 9 years. She has been awarded an Early Career Fellowship as well as two Career Development Fellowships for her research into pancreatic cancer, one in 2017 and one in 2014 (in which she was the top-ranked applicant). This year’s Award recognises the strength of her research program during her time as a CINSW Career Development Fellow.
Dr Pajic says she is overwhelmed at having been named Outstanding Cancer Research Fellow, and at the longterm support she has received from CINSW.
Speaking on November 5, she said, “Two days out, and the excitement is still there. Not only do I feel very honoured to have received such an award, which is significant recognition of my achievements thus far, but more importantly, I realise how much more there needs to be done to truly improve survival of people diagnosed every day with pancreatic cancer. I am determined more than ever to make a difference and help find new and better ways to treat this horrible disease.”
Dr Pajic also paid tribute to those individuals and organisations who have supported her research over the years.
“The philanthropic support of Mrs Jane Hemstritch and the Philip Hemstritch Fellowship in Pancreatic Cancer Research has made a huge difference – and has really given me the opportunity to develop my early concept ideas into sound projects with solid data, and recruit the best individuals to my team,” she said.
“In turn, this has enabled subsequent funding from the NHMRC and Cancer Australia, to convert our projects into new discoveries. Thank you Jane, for your incredible unwavering support over many years!”
“I also want to especially thank the Avner Pancreatic Cancer Foundation, who have put their trust in me and my team and have enabled another exciting project – into the development of novel treatments for pancreatic cancer – through their Innovation Grant. Support like this allows our new (but risky) ideas to be tested and to flourish.
“I’m very lucky to have a truly awesome team of researchers working with me here at Garvan, not to mention fantastic collaborators across Australia and worldwide. My collaborators are not just researchers: I’m very lucky to work closely with Jan Mumford, Professor Ros Pesman AM and Ben Bravery, cancer survivors who provide a crucial consumer voice and help me to keep my work relevant.
“Finally, I would also like to thank the members of the Pancreatic Cancer Alliance, for working tirelessly to raise awareness about pancreatic cancer in our community.”